FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer Read more
Data from GARNET study indicates robust activity of dostarlimab in patients with advanced or recurrent endometrial cancer Read more
AbbVie and Voyager Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson’s Disease and Other Synucleinopathies Read more
OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer Read more
Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration Read more
Japan MHLW Grants Orphan Drug Designation to Axicabtagene Ciloleucel for Treatment of Certain Types of B-Cell Lymphoma Read more